JP2006522115A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006522115A5 JP2006522115A5 JP2006507997A JP2006507997A JP2006522115A5 JP 2006522115 A5 JP2006522115 A5 JP 2006522115A5 JP 2006507997 A JP2006507997 A JP 2006507997A JP 2006507997 A JP2006507997 A JP 2006507997A JP 2006522115 A5 JP2006522115 A5 JP 2006522115A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- receptor antagonist
- angiotensin
- type
- daily dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0300988A SE0300988D0 (sv) | 2003-04-03 | 2003-04-03 | New use |
| PCT/SE2004/000505 WO2004087136A1 (en) | 2003-04-03 | 2004-03-31 | Use of atii antagonist for the treatment or prevention of metabolic syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006522115A JP2006522115A (ja) | 2006-09-28 |
| JP2006522115A5 true JP2006522115A5 (https=) | 2007-04-05 |
Family
ID=20290927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006507997A Pending JP2006522115A (ja) | 2003-04-03 | 2004-03-31 | 代謝症候群の処置または予防のためａｔｉｉアンタゴニストの使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20060194856A1 (https=) |
| EP (1) | EP1613309A1 (https=) |
| JP (1) | JP2006522115A (https=) |
| KR (1) | KR20050114671A (https=) |
| CN (1) | CN1771033A (https=) |
| AU (1) | AU2004226517B2 (https=) |
| BR (1) | BRPI0408979A (https=) |
| CA (1) | CA2520960A1 (https=) |
| IL (1) | IL170706A0 (https=) |
| MX (1) | MXPA05010660A (https=) |
| NO (1) | NO20054370L (https=) |
| NZ (1) | NZ542640A (https=) |
| SE (1) | SE0300988D0 (https=) |
| WO (1) | WO2004087136A1 (https=) |
| ZA (1) | ZA200507945B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008067378A2 (en) * | 2006-11-28 | 2008-06-05 | Auspex Pharmaceuticals, Inc. | Preparation and utility of substituted phenyltetrazoles |
| JP2015509969A (ja) * | 2012-03-16 | 2015-04-02 | グルソックス・バイオテック・アーベー | Ｎｏｘ４阻害活性を示すチオフェン−ベースの化合物および療法におけるその使用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5196444A (en) * | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
| US5266583A (en) * | 1992-09-01 | 1993-11-30 | Merck & Co., Inc. | Angitotensin II antagonist |
| GB9406573D0 (en) * | 1994-03-31 | 1994-05-25 | Merck Sharp & Dohme | Medicaments |
| DE4439947A1 (de) * | 1994-11-09 | 1996-05-15 | Boehringer Mannheim Gmbh | 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| NZ509260A (en) * | 1998-07-10 | 2003-09-26 | Novartis Ag | Pharmaceutical composition containing valsartan and a calcium channel blocker |
| IL152081A0 (en) * | 2000-04-12 | 2003-05-29 | Novartis Ag | Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists |
| CA2420055C (en) * | 2000-08-25 | 2010-06-01 | Takeda Chemical Industries, Ltd. | Fibrinogen-lowering agent |
| US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
| US20030092736A1 (en) * | 2001-05-30 | 2003-05-15 | Cheng Peter T. | Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
| US7232828B2 (en) * | 2002-08-10 | 2007-06-19 | Bethesda Pharmaceuticals, Inc. | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure |
| EP1579872B8 (en) * | 2002-12-27 | 2012-11-07 | Takeda Pharmaceutical Company Limited | Body weight gain inhibitor |
-
2003
- 2003-04-03 SE SE0300988A patent/SE0300988D0/xx unknown
-
2004
- 2004-03-31 EP EP04724927A patent/EP1613309A1/en not_active Ceased
- 2004-03-31 AU AU2004226517A patent/AU2004226517B2/en not_active Ceased
- 2004-03-31 CN CNA2004800093941A patent/CN1771033A/zh active Pending
- 2004-03-31 KR KR1020057017718A patent/KR20050114671A/ko not_active Ceased
- 2004-03-31 US US10/550,760 patent/US20060194856A1/en not_active Abandoned
- 2004-03-31 MX MXPA05010660A patent/MXPA05010660A/es active IP Right Grant
- 2004-03-31 NZ NZ542640A patent/NZ542640A/en not_active IP Right Cessation
- 2004-03-31 CA CA002520960A patent/CA2520960A1/en not_active Abandoned
- 2004-03-31 JP JP2006507997A patent/JP2006522115A/ja active Pending
- 2004-03-31 WO PCT/SE2004/000505 patent/WO2004087136A1/en not_active Ceased
- 2004-03-31 BR BRPI0408979-0A patent/BRPI0408979A/pt not_active IP Right Cessation
-
2005
- 2005-09-06 IL IL170706A patent/IL170706A0/en unknown
- 2005-09-21 NO NO20054370A patent/NO20054370L/no not_active Application Discontinuation
- 2005-09-30 ZA ZA200507945A patent/ZA200507945B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU753486B2 (en) | Method of treatment and pharmaceutical composition | |
| JP2005537854A5 (https=) | ||
| EP1857457A3 (en) | Benzimidazole derivative and its use as AII receptor antagonist | |
| US6395728B2 (en) | Method of treatment and pharmaceutical composition | |
| US6204281B1 (en) | Method of treatment and pharmaceutical composition | |
| RU2004137105A (ru) | Комбинация органических соединений | |
| JP2006526031A5 (https=) | ||
| CA2514921A1 (en) | Combined use of olmesartan medoxomil and azelnidipine or amlodipine for the treatment of arteriosclerosis and hypertension | |
| JP2003531118A5 (https=) | ||
| EP2592070A3 (en) | Tetrazole-substituted arylamides | |
| JP2007522220A5 (https=) | ||
| JP2010507602A5 (https=) | ||
| JP2020506180A5 (https=) | ||
| JP2012510957A5 (https=) | ||
| JP2006528617A5 (https=) | ||
| DE60322680D1 (de) | Opioid-rezeptor-aktive 4-(3-hydroxyphenyl) oder 4-(3-alkoxyphenyl)-1,2,4-triazol-verbindungen | |
| JP2008516004A5 (https=) | ||
| JP2004532828A5 (https=) | ||
| JP2007515467A5 (https=) | ||
| JP2008510789A5 (https=) | ||
| JP2006522115A5 (https=) | ||
| JP2022511588A5 (https=) | ||
| JP2005504776A5 (https=) | ||
| JP2006510659A5 (https=) | ||
| JP2004517947A5 (https=) |